Trials / Conditions / Multiple System Atrophy (MSA)

Multiple System Atrophy (MSA)

13 registered clinical trials studyying Multiple System Atrophy (MSA) — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	MSA-01 in Multiple System Atrophy NCT07446894	Tokyo University	Phase 3
Recruiting	The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy NCT06765733	Beijing Tiantan Hospital	EARLY_Phase 1
Recruiting	[18F]ACI-15916 PET in α-synucleinopathies NCT06891703	AC Immune SA	EARLY_Phase 1
Recruiting	AI-Enhanced Optimization of Acute Levodopa Challenge Test NCT06949865	Beijing Tiantan Hospital	—
Active Not Recruiting	A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy NCT05923866	Ono Pharmaceutical Co., Ltd.	Phase 2
Completed	A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission C NCT04193527	GE Healthcare	Phase 3
Recruiting	Multiple System Atrophy Multidisciplinary Clinic NCT03811808	University of Texas Southwestern Medical Center	—
Completed	AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients NCT02388295	AstraZeneca	Phase 2
Unknown	PROgressive Supranuclear Palsy CorTico-Basal Syndrome Multiple System Atrophy Longitudinal Study UK NCT02778607	University College, London	—
Completed	Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkinsonism NCT06204575	Rambam Health Care Campus	—
Completed	Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI) NCT01888185	Milton S. Hershey Medical Center	—
Completed	Oligomeric Alpha-synuclein in Multiple System Atrophy NCT01485549	University Hospital, Bordeaux	—
No Longer Available	Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA) NCT05086094	Biohaven Pharmaceuticals, Inc.	—